| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infertility, Female | 19 | 2022 | 43 | 3.840 |
Why?
|
| Infertility | 10 | 2022 | 35 | 3.570 |
Why?
|
| Ovulation Induction | 14 | 2022 | 34 | 2.910 |
Why?
|
| Ovarian Follicle | 10 | 2019 | 84 | 2.490 |
Why?
|
| Live Birth | 14 | 2021 | 40 | 2.370 |
Why?
|
| Insemination, Artificial | 9 | 2025 | 27 | 1.760 |
Why?
|
| Polycystic Ovary Syndrome | 14 | 2022 | 65 | 1.660 |
Why?
|
| Pregnancy | 33 | 2025 | 1255 | 1.550 |
Why?
|
| Infertility, Male | 8 | 2022 | 23 | 1.530 |
Why?
|
| Pregnancy Rate | 17 | 2025 | 49 | 1.230 |
Why?
|
| Watchful Waiting | 4 | 2022 | 18 | 1.230 |
Why?
|
| Aging | 11 | 2019 | 1017 | 1.210 |
Why?
|
| Female | 59 | 2025 | 15634 | 1.200 |
Why?
|
| Fertility | 8 | 2022 | 60 | 1.180 |
Why?
|
| Fertility Agents, Female | 8 | 2022 | 15 | 1.170 |
Why?
|
| Luteal Phase | 2 | 2019 | 7 | 1.170 |
Why?
|
| Progesterone | 3 | 2019 | 130 | 1.110 |
Why?
|
| Pregnancy, Ectopic | 4 | 2021 | 11 | 1.080 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 3 | 2021 | 5 | 1.050 |
Why?
|
| Reproduction | 4 | 2012 | 64 | 1.040 |
Why?
|
| Humans | 67 | 2025 | 28884 | 0.940 |
Why?
|
| Adult | 44 | 2025 | 8030 | 0.900 |
Why?
|
| Ovary | 3 | 2013 | 72 | 0.890 |
Why?
|
| Reproductive Techniques, Assisted | 5 | 2021 | 17 | 0.870 |
Why?
|
| Hysterosalpingography | 2 | 2020 | 4 | 0.800 |
Why?
|
| Embryo Transfer | 3 | 2021 | 13 | 0.790 |
Why?
|
| Fertilization in Vitro | 6 | 2021 | 24 | 0.770 |
Why?
|
| Proprotein Convertases | 1 | 2022 | 12 | 0.750 |
Why?
|
| Models, Biological | 3 | 2014 | 469 | 0.740 |
Why?
|
| Prospective Studies | 14 | 2022 | 1280 | 0.740 |
Why?
|
| Insulin Resistance | 3 | 2022 | 176 | 0.730 |
Why?
|
| Life Style | 3 | 2022 | 91 | 0.720 |
Why?
|
| Progestins | 2 | 2019 | 12 | 0.710 |
Why?
|
| Cryopreservation | 2 | 2021 | 13 | 0.680 |
Why?
|
| Ovarian Reserve | 2 | 2019 | 9 | 0.630 |
Why?
|
| Ultrasonography | 6 | 2018 | 243 | 0.630 |
Why?
|
| Gonadotropins | 5 | 2020 | 22 | 0.600 |
Why?
|
| Spermatozoa | 4 | 2025 | 34 | 0.580 |
Why?
|
| Biomarkers | 8 | 2022 | 777 | 0.570 |
Why?
|
| Estradiol | 4 | 2014 | 176 | 0.570 |
Why?
|
| Chorionic Gonadotropin | 3 | 2021 | 22 | 0.530 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 24 | 0.500 |
Why?
|
| Pregnancy Outcome | 6 | 2021 | 131 | 0.500 |
Why?
|
| Obesity | 6 | 2022 | 701 | 0.490 |
Why?
|
| Clomiphene | 5 | 2021 | 11 | 0.480 |
Why?
|
| Sperm Count | 4 | 2025 | 17 | 0.470 |
Why?
|
| Premenopause | 1 | 2015 | 20 | 0.470 |
Why?
|
| Off-Label Use | 1 | 2015 | 6 | 0.450 |
Why?
|
| Drug Labeling | 1 | 2015 | 4 | 0.450 |
Why?
|
| Endometriosis | 1 | 2015 | 19 | 0.450 |
Why?
|
| Birth Rate | 1 | 2014 | 11 | 0.450 |
Why?
|
| Drug Prescriptions | 1 | 2015 | 46 | 0.440 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2012 | 71 | 0.440 |
Why?
|
| Ovariectomy | 2 | 2012 | 53 | 0.410 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 6 | 0.410 |
Why?
|
| Semen | 3 | 2022 | 29 | 0.390 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 146 | 0.380 |
Why?
|
| Treatment Outcome | 11 | 2022 | 2426 | 0.370 |
Why?
|
| Abortion, Spontaneous | 3 | 2021 | 17 | 0.370 |
Why?
|
| Male | 20 | 2025 | 13934 | 0.360 |
Why?
|
| Pregnancy, Multiple | 3 | 2015 | 8 | 0.350 |
Why?
|
| Young Adult | 15 | 2022 | 2839 | 0.350 |
Why?
|
| Insemination | 2 | 2020 | 6 | 0.330 |
Why?
|
| Methotrexate | 2 | 2021 | 36 | 0.320 |
Why?
|
| Sperm Motility | 3 | 2025 | 16 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2022 | 404 | 0.310 |
Why?
|
| 5'-Nucleotidase | 4 | 2002 | 13 | 0.300 |
Why?
|
| Body Mass Index | 5 | 2022 | 412 | 0.300 |
Why?
|
| Antioxidants | 2 | 2021 | 224 | 0.290 |
Why?
|
| Inhibins | 4 | 2012 | 8 | 0.290 |
Why?
|
| Follicular Phase | 2 | 2004 | 8 | 0.280 |
Why?
|
| Middle Aged | 10 | 2019 | 7416 | 0.270 |
Why?
|
| Adolescent | 13 | 2021 | 3197 | 0.270 |
Why?
|
| United States | 8 | 2022 | 2225 | 0.250 |
Why?
|
| Triazoles | 2 | 2015 | 16 | 0.230 |
Why?
|
| Nitriles | 2 | 2015 | 38 | 0.230 |
Why?
|
| Patient Selection | 2 | 2015 | 150 | 0.220 |
Why?
|
| Risk Factors | 7 | 2022 | 2127 | 0.220 |
Why?
|
| Triglycerides | 2 | 2022 | 123 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2025 | 2635 | 0.210 |
Why?
|
| Galanin-Like Peptide | 1 | 2003 | 1 | 0.210 |
Why?
|
| Infant, Newborn | 4 | 2020 | 916 | 0.200 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 68 | 0.200 |
Why?
|
| Insemination, Artificial, Homologous | 2 | 2020 | 4 | 0.190 |
Why?
|
| Metabolic Syndrome | 2 | 2021 | 80 | 0.190 |
Why?
|
| Dilatation and Curettage | 2 | 2021 | 4 | 0.190 |
Why?
|
| Androgens | 2 | 2020 | 47 | 0.190 |
Why?
|
| Chi-Square Distribution | 4 | 2015 | 145 | 0.190 |
Why?
|
| Proprotein Convertase 9 | 1 | 2022 | 4 | 0.190 |
Why?
|
| Subtilisins | 1 | 2022 | 6 | 0.190 |
Why?
|
| Semen Analysis | 4 | 2025 | 13 | 0.190 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 64 | 0.190 |
Why?
|
| Testosterone | 2 | 2019 | 74 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 485 | 0.180 |
Why?
|
| Decision Support Techniques | 1 | 2022 | 51 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2022 | 897 | 0.180 |
Why?
|
| Lipoproteins | 1 | 2022 | 99 | 0.180 |
Why?
|
| Vitamins | 1 | 2021 | 23 | 0.180 |
Why?
|
| Hydrocortisone | 1 | 2022 | 89 | 0.180 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2012 | 6 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2022 | 82 | 0.170 |
Why?
|
| Sleep | 1 | 2021 | 112 | 0.170 |
Why?
|
| Cholesterol | 1 | 2022 | 203 | 0.170 |
Why?
|
| Endometrium | 1 | 2020 | 39 | 0.170 |
Why?
|
| Ethiodized Oil | 1 | 2020 | 2 | 0.170 |
Why?
|
| Fertility Agents | 1 | 2020 | 2 | 0.160 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2015 | 37 | 0.160 |
Why?
|
| Fertilization | 2 | 2022 | 10 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 1002 | 0.160 |
Why?
|
| Child Behavior | 1 | 2020 | 30 | 0.160 |
Why?
|
| Child | 3 | 2020 | 2291 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 112 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 20 | 0.160 |
Why?
|
| Reproductive Medicine | 2 | 2018 | 4 | 0.160 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 25 | 0.160 |
Why?
|
| Metformin | 1 | 2020 | 36 | 0.160 |
Why?
|
| Contrast Media | 1 | 2020 | 96 | 0.150 |
Why?
|
| Fallopian Tubes | 2 | 2018 | 15 | 0.150 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 15 | 0.150 |
Why?
|
| Water | 1 | 2020 | 135 | 0.150 |
Why?
|
| Ovulation | 2 | 2018 | 28 | 0.150 |
Why?
|
| Spermatogenesis | 1 | 2019 | 11 | 0.150 |
Why?
|
| Leiomyoma | 1 | 2019 | 9 | 0.150 |
Why?
|
| Child Development | 1 | 2020 | 79 | 0.150 |
Why?
|
| Endocrinologists | 1 | 2019 | 2 | 0.150 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2018 | 2 | 0.150 |
Why?
|
| Ethics Committees, Research | 1 | 2018 | 6 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2018 | 46 | 0.140 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 49 | 0.140 |
Why?
|
| Menstrual Cycle | 2 | 2012 | 24 | 0.140 |
Why?
|
| Gynecology | 1 | 2019 | 60 | 0.140 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 29 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 787 | 0.140 |
Why?
|
| Vitamin D | 1 | 2018 | 51 | 0.140 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 31 | 0.140 |
Why?
|
| Transcriptome | 1 | 2019 | 231 | 0.130 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 69 | 0.130 |
Why?
|
| Quality of Life | 2 | 2019 | 521 | 0.130 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 6 | 0.130 |
Why?
|
| Depression | 1 | 2019 | 225 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2021 | 677 | 0.130 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 127 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2015 | 176 | 0.120 |
Why?
|
| Contraceptives, Oral | 1 | 2015 | 23 | 0.120 |
Why?
|
| Chlamydia trachomatis | 1 | 2015 | 16 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 17 | 0.120 |
Why?
|
| Patient Dropouts | 1 | 2015 | 6 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 48 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2002 | 344 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 995 | 0.120 |
Why?
|
| Ovulation Inhibition | 1 | 2015 | 1 | 0.110 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2015 | 9 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2015 | 98 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 103 | 0.110 |
Why?
|
| Organ Size | 2 | 2020 | 88 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 46 | 0.110 |
Why?
|
| Time Factors | 2 | 2018 | 1613 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2015 | 134 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2018 | 739 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 26 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2014 | 391 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 272 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 465 | 0.100 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2013 | 4 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 1994 | 111 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2013 | 81 | 0.100 |
Why?
|
| Research Design | 2 | 2019 | 187 | 0.100 |
Why?
|
| Prevalence | 3 | 2019 | 518 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2022 | 631 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2012 | 35 | 0.090 |
Why?
|
| Smoking | 1 | 2015 | 478 | 0.090 |
Why?
|
| Infant | 2 | 2020 | 1025 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2019 | 202 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2020 | 1173 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 1032 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2003 | 668 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 302 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 416 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 841 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2020 | 422 | 0.070 |
Why?
|
| Anthropometry | 1 | 2008 | 93 | 0.070 |
Why?
|
| Hyperandrogenism | 2 | 2018 | 11 | 0.070 |
Why?
|
| Observer Variation | 2 | 2007 | 46 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 2007 | 11 | 0.070 |
Why?
|
| Ureteral Obstruction | 1 | 2007 | 12 | 0.060 |
Why?
|
| Base Sequence | 4 | 1995 | 589 | 0.060 |
Why?
|
| Animals | 4 | 2013 | 10699 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1995 | 208 | 0.060 |
Why?
|
| Stents | 1 | 2007 | 121 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 1995 | 1056 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 811 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 254 | 0.060 |
Why?
|
| Phenotype | 2 | 2018 | 686 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2015 | 237 | 0.060 |
Why?
|
| Inhibin-beta Subunits | 1 | 2004 | 3 | 0.050 |
Why?
|
| Activins | 1 | 2004 | 4 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 7 | 0.050 |
Why?
|
| Metabolism | 1 | 2003 | 9 | 0.050 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2003 | 5 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2003 | 53 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 76 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2003 | 22 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2003 | 22 | 0.050 |
Why?
|
| Ion Channels | 1 | 2003 | 28 | 0.050 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2003 | 14 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 200 | 0.050 |
Why?
|
| Eating | 1 | 2003 | 71 | 0.050 |
Why?
|
| Leptin | 1 | 2003 | 67 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 224 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 80 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 410 | 0.050 |
Why?
|
| Body Weight | 1 | 2003 | 250 | 0.050 |
Why?
|
| alpha-Amylases | 1 | 2022 | 3 | 0.050 |
Why?
|
| Coitus | 1 | 2022 | 14 | 0.050 |
Why?
|
| Maternal Age | 1 | 2022 | 25 | 0.050 |
Why?
|
| Snoring | 1 | 2021 | 8 | 0.050 |
Why?
|
| Preconception Care | 1 | 2022 | 18 | 0.040 |
Why?
|
| Uterine Hemorrhage | 1 | 2021 | 9 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 255 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 63 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 36 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 83 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 43 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2002 | 198 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 65 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 465 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 96 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 249 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 303 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2020 | 47 | 0.040 |
Why?
|
| Gestures | 1 | 2020 | 1 | 0.040 |
Why?
|
| Rats | 1 | 2003 | 1588 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 69 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 31 | 0.040 |
Why?
|
| Weight Gain | 1 | 2020 | 76 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 55 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 20 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 485 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 20 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 82 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 490 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 110 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2002 | 523 | 0.040 |
Why?
|
| Birth Weight | 1 | 2018 | 63 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 464 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 1658 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 397 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 152 | 0.030 |
Why?
|
| Asian Americans | 1 | 2018 | 40 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 737 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 379 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 498 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2017 | 4 | 0.030 |
Why?
|
| Hirsutism | 1 | 2017 | 18 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 20 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2017 | 8 | 0.030 |
Why?
|
| Mice | 3 | 2003 | 4808 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 404 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 331 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2018 | 156 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 1995 | 5 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1995 | 66 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 19 | 0.030 |
Why?
|
| African Americans | 1 | 2018 | 352 | 0.030 |
Why?
|
| Base Composition | 1 | 1995 | 110 | 0.030 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1995 | 2 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1995 | 94 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 310 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 202 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 257 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 209 | 0.030 |
Why?
|
| Binding Sites | 1 | 1995 | 355 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 125 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 126 | 0.030 |
Why?
|
| RNA Caps | 1 | 1994 | 2 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 10 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 24 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1994 | 23 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 12 | 0.030 |
Why?
|
| Epididymis | 1 | 2013 | 8 | 0.030 |
Why?
|
| Placenta | 1 | 1994 | 78 | 0.020 |
Why?
|
| Indians, North American | 1 | 2018 | 544 | 0.020 |
Why?
|
| Superovulation | 1 | 2012 | 6 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 4 | 0.020 |
Why?
|
| Coffee | 1 | 2012 | 5 | 0.020 |
Why?
|
| Tea | 1 | 2012 | 7 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2012 | 46 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2007 | 35 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 122 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1995 | 133 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2004 | 57 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 697 | 0.010 |
Why?
|
| Apyrase | 1 | 2002 | 4 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 25 | 0.010 |
Why?
|
| Permeability | 1 | 2002 | 61 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2002 | 35 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 50 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 59 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 140 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 1022 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 634 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 62 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1995 | 77 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 147 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 278 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1993 | 9 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 202 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1993 | 82 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 515 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 270 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 377 | 0.010 |
Why?
|